Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 21 10:51AM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.02 Insider Own3.02% Shs Outstand226.06M Perf Week-0.14%
Market Cap2.50B Forward P/E19.94 EPS next Y0.54 Insider Trans-18.60% Shs Float224.80M Perf Month12.14%
Income-3.64M PEG- EPS next Q0.08 Inst Own75.62% Short Float4.10% Perf Quarter73.91%
Sales283.18M P/S8.81 EPS this Y371.15% Inst Trans7.28% Short Ratio3.34 Perf Half Y155.09%
Book/sh0.66 P/B16.23 EPS next Y53.19% ROA-1.05% Short Interest9.21M Perf Year172.53%
Cash/sh0.20 P/C55.05 EPS next 5Y- ROE-2.43% 52W Range3.06 - 10.99 Perf YTD138.16%
Dividend Est.- P/FCF154.71 EPS past 5Y38.68% ROI-1.24% 52W High-2.05% Beta0.54
Dividend TTM- Quick Ratio1.86 Sales past 5Y73.26% Gross Margin39.13% 52W Low251.80% ATR (14)0.33
Dividend Ex-Date- Current Ratio5.21 EPS Y/Y TTM92.61% Oper. Margin15.63% RSI (14)75.99 Volatility2.95% 3.02%
Employees624 Debt/Eq0.92 Sales Y/Y TTM55.69% Profit Margin-1.29% Recom1.00 Target Price10.50
Option/ShortYes / Yes LT Debt/Eq0.91 EPS Q/Q346.08% Payout- Rel Volume1.00 Prev Close10.71
Sales Surprise5.95% EPS Surprise62.00% Sales Q/Q43.86% EarningsMay 09 AMC Avg Volume2.76M Price10.77
SMA206.07% SMA5028.72% SMA20095.87% Trades Volume682,268 Change0.51%
Date Action Analyst Rating Change Price Target Change
Jul-19-23Resumed Raymond James Strong Buy $5
Oct-13-22Initiated Mizuho Buy $5
Nov-11-21Upgrade Raymond James Outperform → Strong Buy $5
Nov-09-21Initiated Cantor Fitzgerald Overweight $4.50
Jun-04-19Initiated Jefferies Buy $8
Apr-15-19Reiterated H.C. Wainwright Buy $10 → $13
Feb-07-19Resumed H.C. Wainwright Buy $10
Dec-11-17Reiterated Maxim Group Buy $13 → $8
Nov-14-17Upgrade Raymond James Mkt Perform → Outperform
Jan-23-17Upgrade Maxim Group Hold → Buy $13
Jun-20-24 05:50PM
Jun-11-24 09:30AM
May-13-24 09:40AM
May-10-24 02:26PM
10:57AM Loading…
May-09-24 06:20PM
May-02-24 05:45PM
Apr-30-24 09:30AM
Apr-29-24 11:26AM
Apr-25-24 05:45PM
08:50AM Loading…
Apr-24-24 08:50AM
Apr-19-24 05:45PM
Apr-17-24 05:50PM
Apr-10-24 05:45PM
Apr-09-24 11:07AM
Apr-05-24 08:50AM
Apr-01-24 05:50PM
Mar-22-24 05:50PM
Mar-20-24 08:50AM
Mar-18-24 09:55AM
Mar-15-24 05:50PM
Mar-11-24 07:00AM
Mar-05-24 12:00PM
08:50AM Loading…
Mar-04-24 08:50AM
Mar-01-24 09:55AM
Feb-29-24 11:06AM
Feb-28-24 05:30PM
Feb-22-24 05:45PM
Feb-21-24 05:50PM
Feb-15-24 05:45PM
Feb-07-24 05:45PM
Feb-06-24 09:30AM
Feb-05-24 09:55AM
Feb-02-24 05:50PM
Jan-30-24 08:50AM
Jan-19-24 09:55AM
Jan-17-24 09:30AM
Jan-10-24 08:50AM
Jan-08-24 07:00AM
Jan-05-24 12:00PM
Dec-26-23 09:30AM
Dec-25-23 09:55AM
Dec-18-23 04:05PM
Dec-12-23 07:00AM
Dec-08-23 09:30AM
Dec-06-23 09:40AM
Nov-22-23 09:30AM
Nov-17-23 06:29PM
Nov-16-23 07:00AM
Nov-10-23 11:05AM
Nov-09-23 04:25PM
Nov-08-23 04:49PM
Nov-06-23 09:30AM
Nov-02-23 05:45PM
Nov-01-23 07:00AM
Oct-27-23 05:45PM
Oct-25-23 05:50PM
Oct-17-23 05:50PM
Oct-09-23 05:50PM
Sep-29-23 09:30AM
Sep-27-23 05:50PM
Sep-21-23 05:50PM
Sep-14-23 05:50PM
Sep-13-23 09:30AM
Aug-10-23 02:31PM
Aug-09-23 06:40PM
Aug-02-23 07:00AM
Jul-28-23 08:59AM
Jul-26-23 11:30AM
Jul-25-23 05:12PM
Jul-20-23 05:50PM
Jul-19-23 07:00AM
Jul-13-23 05:50PM
Jul-07-23 07:32AM
Jun-23-23 10:31AM
Jun-22-23 09:18AM
Jun-21-23 03:21PM
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grossman Adam SPresident,CEO, and Interim CFOJun 14 '24Sale10.72100,0001,071,9802,081,475Jun 14 09:00 PM
ELMS STEVEDirectorMar 19 '24Sale6.08411,8292,503,9202,115,671Mar 19 09:48 PM
ELMS STEVEDirectorMar 18 '24Sale6.0149,887299,8212,527,500Mar 19 09:48 PM
ELMS STEVEDirectorMar 15 '24Sale6.01183,0081,099,8782,577,387Mar 15 09:00 PM
ELMS STEVEDirectorMar 14 '24Sale6.05448,2762,712,0702,760,395Mar 15 09:00 PM
ELMS STEVEDirectorMar 13 '24Sale6.21407,0002,527,4703,208,671Mar 15 09:00 PM
Grossman Jerrold BDirectorAug 30 '23Buy3.71130,000482,144443,265Aug 30 04:58 PM
KWON YOUNGDirectorAug 24 '23Buy3.9025,00097,500277,401Aug 24 07:53 PM
Fong BryantDirectorAug 22 '23Sale3.871,433,3045,544,7370Aug 23 08:30 PM
Grossman Adam SPresident and CEOAug 18 '23Sale4.15250,0001,038,3502,273,085Aug 18 09:46 PM
LENZ BRIANEVP, CFOAug 16 '23Sale4.45178,184793,400782,013Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 16 '23Sale4.383132,523,085Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 15 '23Option Exercise3.112,100,4596,536,4484,623,544Aug 17 09:30 PM
LENZ BRIANEVP, CFOAug 15 '23Option Exercise3.11809,2622,514,3631,591,275Aug 17 09:30 PM
Grossman Adam SPresident and CEOAug 15 '23Sale4.54510,4692,318,9594,113,075Aug 17 09:30 PM
LENZ BRIANEVP, CFOAug 15 '23Sale4.60211,578972,730782,013Aug 17 09:30 PM